Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Cytokinetics, Incorporated - Common Stock (NQ:CYTK)

66.27 +1.42 (+2.19%)
Streaming Delayed Price Updated: 2:25 PM EST, Feb 11, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Cytokinetics, Incorporated - Common Stock

< Previous 1 2 3 4 5 6 7 8 9
...
14 15 Next >
News headline image
Cytokinetics Shareholder Alert: ClaimsFiler Reminds Investors With Losses In Excess Of $100,000 Of Lead Plaintiff Deadline In Class Action Lawsuits Against Cytokinetics, Incorporated - CYTK
From SkyMedia, LLC
Via GlobeNewswire
News headline image
ROSEN, A RANKED AND LEADING LAW FIRM, Encourages Cytokinetics, Inc. Investors to Secure Counsel Before Important November 17 Deadline in Securities Class Action – CYTK
From The Rosen Law Firm PA
Via GlobeNewswire
News headline image
Cytokinetics (CYTK) Q3 2025 Earnings Transcript ↗
Cytokinetics (CYTK) Q3 2025 Earnings Transcript 
Via The Motley Fool
News headline image
Earnings Scheduled For November 5, 2025 ↗
 
Via Benzinga
News headline image
Cytokinetics, Incorporated Class Action: Levi & Korsinsky Reminds Cytokinetics Investors of the Pending Class Action Lawsuit With a Lead Plaintiff Deadline of November 17, 2025 - CYTK
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations. 
Via NewMediaWire
Topics Earnings Fraud Lawsuit
News headline image
Cytokinetics, Incorporated Class Action: Levi &amp; Korsinsky Reminds Cytokinetics Investors of the Pending Class Action Lawsuit With a Lead Plaintiff Deadline of November 17, 2025 - CYTK
Via TheNewswire.com
Topics Earnings Fraud Lawsuit
News headline image
Cytokinetics Shareholder Alert By Former Louisiana Attorney General: Kahn Swick & Foti, LLC Reminds Investors with Losses in Excess of $100,000 of Lead Plaintiff Deadline in Class Action Lawsuit Against Cytokinetics, Incorporated - CYTK
From Kahn Swick & Foti, LLC
Via GlobeNewswire
News headline image
Levi & Korsinsky Announces the Filing of a Securities Class Action on Behalf of Cytokinetics, Incorporated (CYTK) Shareholders
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations. 
Via NewMediaWire
Topics Earnings Fraud Lawsuit
News headline image
Levi &amp; Korsinsky Announces the Filing of a Securities Class Action on Behalf of Cytokinetics, Incorporated (CYTK) Shareholders
Via TheNewswire.com
Topics Earnings Fraud Lawsuit
News headline image
CYTK INVESTOR NOTICE: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Cytokinetics
From Faruqi & Faruqi LLP
Via GlobeNewswire
News headline image
CYTK INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces That Cytokinetics, Incorporated Investors With Substantial Losses Have Opportunity to Lead Class Action Lawsuit
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations. 
Via NewMediaWire
Topics Fraud Lawsuit
News headline image
CYTK INVESTOR ALERT: Bronstein, Gewirtz &amp; Grossman LLC Announces That Cytokinetics, Incorporated Investors With Substantial Losses Have Opportunity to Lead Class Action Lawsuit
Via TheNewswire.com
Topics Fraud Lawsuit
News headline image
CYTOKINETICS CLASS ACTION: Bragar Eagel & Squire, P.C. Urges Cytokinetics Stockholders to Contact the Firm Regarding Their Rights Before November 17th
From Bragar Eagel & Squire
Via GlobeNewswire
News headline image
CYTK Investors Have Opportunity to Lead Cytokinetics, Incorporated Securities Fraud Lawsuit with the Schall Law Firm
From Schall Law
Via GlobeNewswire
News headline image
CYTK Investors Have Opportunity to Lead Cytokinetics, Incorporated Securities Fraud Lawsuit with the Schall Law Firm
From Schall Law
Via GlobeNewswire
News headline image
Contact Levi &amp; Korsinsky by November 17, 2025 Deadline to Join Class Action Against Cytokinetics, Incorporated (CYTK)
Via TheNewswire.com
Topics Earnings Fraud Lawsuit
News headline image
Contact Levi & Korsinsky by November 17, 2025 Deadline to Join Class Action Against Cytokinetics, Incorporated (CYTK)
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations. 
Via NewMediaWire
Topics Earnings Fraud Lawsuit
News headline image
SHAREHOLDER NOTICE: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Cytokinetics
From Faruqi & Faruqi LLP
Via GlobeNewswire
News headline image
INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Cytokinetics, Incorporate of Class Action Lawsuit and Upcoming Deadlines – CYTK
From Pomerantz LLP
Via GlobeNewswire
News headline image
Shareholders That Lost Money on Cytokinetics, Incorporated (CYTK) Urged to Join Class Action - Contact Levi & Korsinsky to Learn More
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations. 
Via NewMediaWire
Topics Earnings Fraud Lawsuit
News headline image
Shareholders That Lost Money on Cytokinetics, Incorporated (CYTK) Urged to Join Class Action - Contact Levi &amp; Korsinsky to Learn More
Via TheNewswire.com
Topics Earnings Fraud Lawsuit
News headline image
Cytokinetics Shareholder Alert: ClaimsFiler Reminds Investors With Losses In Excess Of $100,000 Of Lead Plaintiff Deadline In Class Action Lawsuits Against Cytokinetics, Incorporated - CYTK
From SkyMedia, LLC
Via GlobeNewswire
News headline image
CYTOKINETICS CLASS ACTION REMINDER: Bragar Eagel & Squire, P.C. Urgently Reminds CYTK Investors to Contact the Firm Before November 17th
From Bragar Eagel & Squire
Via GlobeNewswire
News headline image
CYTK INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces That Cytokinetics, Incorporated Investors With Substantial Losses Have Opportunity to Lead Class Action Lawsuit
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations. 
Via NewMediaWire
Topics Fraud Lawsuit
News headline image
CYTK INVESTOR ALERT: Bronstein, Gewirtz &amp; Grossman LLC Announces That Cytokinetics, Incorporated Investors With Substantial Losses Have Opportunity to Lead Class Action Lawsuit
Via TheNewswire.com
Topics Fraud Lawsuit
News headline image
Investors in Cytokinetics, Incorporated Should Contact Levi & Korsinsky Before November 17, 2025 to Discuss Your Rights - CYTK
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations. 
Via NewMediaWire
Topics Earnings Fraud Lawsuit
News headline image
Investors in Cytokinetics, Incorporated Should Contact Levi &amp; Korsinsky Before November 17, 2025 to Discuss Your Rights - CYTK
Via TheNewswire.com
Topics Earnings Fraud Lawsuit
News headline image
Cytokinetics Shareholder Alert By Former Louisiana Attorney General: Kahn Swick & Foti, LLC Reminds Investors with Losses in Excess of $100,000 of Lead Plaintiff Deadline in Class Action Lawsuit Against Cytokinetics, Incorporated - CYTK
From Kahn Swick & Foti, LLC
Via GlobeNewswire
News headline image
CYTK Investors Have Opportunity to Lead Cytokinetics, Incorporated Securities Fraud Lawsuit with the Schall Law Firm
From Schall Law
Via GlobeNewswire
News headline image
Levi & Korsinsky Notifies Shareholders of Cytokinetics, Incorporated (CYTK) of a Class Action Lawsuit and an Upcoming Deadline
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations. 
Via NewMediaWire
Topics Earnings Fraud Lawsuit
< Previous 1 2 3 4 5 6 7 8 9
...
14 15 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.